Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Notes Payables (2016 - 2026)

Eastman Chemical (EMN) has disclosed Notes Payables for 18 consecutive years, with $770.0 million as the latest value for Q1 2026.

  • For Q1 2026, Notes Payables rose 170.18% year-over-year to $770.0 million; the TTM value through Mar 2026 reached $770.0 million, up 170.18%, while the annual FY2025 figure was $586.0 million, 30.22% up from the prior year.
  • Notes Payables hit $770.0 million in Q1 2026 for Eastman Chemical, up from $586.0 million in the prior quarter.
  • Across five years, Notes Payables topped out at $1.1 billion in Q4 2022 and bottomed at $285.0 million in Q1 2025.
  • Average Notes Payables over 5 years is $695.5 million, with a median of $697.0 million recorded in 2024.
  • Year-over-year, Notes Payables surged 203.7% in 2022 and then tumbled 61.49% in 2025.
  • Eastman Chemical's Notes Payables stood at $1.1 billion in 2022, then tumbled by 51.95% to $541.0 million in 2023, then decreased by 16.82% to $450.0 million in 2024, then skyrocketed by 30.22% to $586.0 million in 2025, then soared by 31.4% to $770.0 million in 2026.
  • According to Business Quant data, Notes Payables over the past three periods came in at $770.0 million, $586.0 million, and $290.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.